DOCSLIB.ORG

Reports to the Twenty-Fourth Legislature

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Reports to the Twenty-Fourth Legislature REPORTS TO THE TWENTY-FOURTH LEGISLATURE SUBMITTED BY THE OFFICE OF THE ADMINISTRATIVE DIRECTOR OF THE COURTS THE JUDICIARY, STATE OF HAWAI#I DECEMBER 2007 TABLE OF CONTENTS I. Act 232, Session Laws of Hawai#i 1994, HRS §607-3.6 Report on the Spouse and Child Abuse Special Account, including an accounting of the receipts of and expenditures from the account. II. Act 274, Session Laws of Hawai#i 1997, HRS §607-5.6 Report on the Parent Education Special Fund, including an accounting of all deposits into and expenditures from the fund. III. Act 162, Session Laws of Hawai#i 2002, HRS §577-7.5 Report on Parental Preferences in Government contracts. IV. Act 169, Session Laws of Hawai#i 2007, Section 7 Report on the Interagency Council on Intermediate Sanctions: providing a breakdown of expenditures and treatment services provided, costs incurred and treatment outcomes, results of evaluation performed, and analysis of the effectiveness of the project. V. Act 169, Session Laws of Hawai#i 2007, Sections 8, 9, and 10 Report on the use of monies for medically targeted substance abuse treatment for drug addicted offenders - integrated approach supervised by physicians. VI. Act 169, Session Laws of Hawai#i 2007, Section 11 Report on all revenues and expenditures from the court interpreting services revolving fund. VII. Act 169, Session Laws of Hawai#i 2007, Section 12 Report on the status of implementation of the court interpreter program, including a detailed evaluation of services provided and effectiveness of the program. VIII. Senate Concurrent Resolution No. 175, Regular Session 2007 Progress report of the Judiciary in meeting the requirements of Act 206, Session Laws of Hawai#i 1998, relating to the collection of crime victim compensation fees. ANNUAL REPORT TO THE TWENTY-FOURTH LEGISLATURE ON ACT 232 SESSION LAWS OF HAWAI#I 1994 A Report on Spouse and Child Abuse Special Account Submitted by: Office of the Administrative Director of the Courts The Judiciary, State of Hawai#i December 2007 SPOUSE AND CHILD ABUSE SPECIAL ACCOUNT The Spouse and Child Abuse Special Account, placed in the Judiciary, was created in 1994 by the Legislature, State of Hawai#i, for the purposes of developing and/or expanding new and existing programs. The scope may include, but is not limited to, grants or purchase of services which support or provide domestic violence or child abuse intervention or prevention, as authorized by law, and staff programs, as well. The Judiciary’s Special Account is financed through a portion of the monies collected from the issuance of birth, death, and marriage certificates. In addition, any fines collected pursuant to Hawai#i Revised Statutes Chapter 586-11 (Violation for an Order for Protection) and contributions from state tax refunds are deposited into the Special Account. PROGRAMS AND ACTIVITIES FUNDED THROUGH THE SPOUSE AND CHILD ABUSE SPECIAL ACCOUNT Monies from the Judiciary’s Special Account provided a broad range of programs, projects and activities statewide, which addressed the intervention and/or prevention of domestic violence and child abuse. The process of determining which services, programs and activities received priority funding involved internal planning and collaboration of the Judiciary, both internally, as well as coordination with other private and public stakeholders in the community. A total of $434,025 was spent in Fiscal Year (FY) 2006-2007. The annual ceiling on expenditures, as determined by the Legislature is $500,000 per fiscal year. The programs, projects and activities funded by the Special Account include the following: PURCHASE OF SERVICES: The following nonprofit organizations received funding to provide or supplement their contracted services with the Judiciary: i Catholic Charities Hawai#i Assessment and specialized treatment services were provided to juveniles adjudicated for sexual offending in the First Circuit (island of O#ahu) and in the Third Circuit (island of Hawai#i). i Child and Family Service The Developing Options to Violence Program in the First Circuit provided intervention services to juveniles adjudicated for abuse of a family or household member, or involved in intimate partner violence. i Domestic Violence Clearinghouse and Legal Hotline Additional advocacy services were provided to victims of intimate partner violence, in the First Circuit, who filed petitions for temporary restraining orders and orders of protection. Services included assessments, information and referrals, development of safety plans, and accompaniment in court proceedings. i Island of Hawi#i YMCA Supervised child visitation/exchange services for families involved in domestic violence and/or high conflict cases were provided through the YMCA’s Family Visitation Center in East Hawai#i. i Parents and Children Together Supervised child visitation/exchange services for families involved in domestic violence and/or high conflict cases were provided at the Family Visitation Centers in the First Circuit, Second Circuit (island of Maui), and the Fifth Circuit (island of Kaua#i) during this fiscal period. The majority of cases were referred by the Judiciary. i YWCA of Kaua#i Funds were used to augment services to offenders convicted of domestic abuse, sentenced to probation in the Fifth Circuit and mandated to attend treatment. FEDERAL GRANT PROJECTS Matching funds from the Special Account were used for the two federally funded grant projects described below: i State Access and Visitation Program Grant was awarded to the Judiciary by the U.S. Department of Health and Human Services, and provided supervised child visitations and exchanges in a safe and neutral setting. Services were provided on the islands of O#ahu and Hawai#i, with priority given to court referred families involved in domestic violence and/or high conflict situations. Parents were involved in a range of court filings, including domestic abuse, protection orders, divorce, paternity, or child support. Matching funds in excess of the required 10% were provided in response to the high volume of these services requested. i STOP Violence Against Women Act (VAWA) Grant from the U.S. Department of Justice and administered by the state of Hawai#i, Department of the Attorney General, was awarded to the Judiciary. The required 25% state match was taken from the Special Account. This VAWA grant was used during the past fiscal year to permit the continuance of Family Visitation Centers on the islands of Maui and Kaua#i. The Centers provided supervised child visitation services. These two Centers had previously been funded through another Federal grant, and were left with a period of approximately six (6) months to wait before the next funding cycle could resume. Without the use of funds from the Judiciary’s VAWA grant, these two sites would have had to close for several months, thus leaving the families on Maui and Kaua#i without any supervised visitation services. TRAINING/MEETINGS, ETC. During FY 2006-2007, the Special Account made it possible for staff and others in the community to participate in intra-state and inter-state training on a range of subjects such as foster care, domestic violence, child custody and domestic violence, and supervised child visitation services and issues. Publications on domestic violence were also purchased through the Special Account. Monies were also used to cover expenses to conduct a site visit of grant funded activities and to participate in a multi-disciplinary program evaluation of a domestic violence offender program on the island of Hawai#i. COLLABORATION A committee composed of domestic violence advocacy organizations, the Department of Human Services, Child Welfare Services Branch, and the Judiciary have been meeting for approximately three years to promote systems’ collaboration and networking, and improve outcomes for victims of domestic violence and their children, who are involved in the child abuse and neglect cases. The Judiciary’s Special Account funds were used to hire a facilitator to assist the committee in developing strategy and planning. CONSULTATION Consultation services from Lee Stein, MSW, CSAC, a private consultant in Hawai#i, with expertise in domestic violence, substance abuse, Motivational Interviewing, and other areas, were obtained to assist the Judiciary. She continued the work initiated in the previous fiscal year to provide the contracted domestic violence batterers intervention service programs with technical assistance in curriculum development. In addition, on-site classes in Motivational Interviewing were conducted for all Judiciary contracted programs that worked with domestic violence batterers. SUMMARY The Judiciary’s Spouse and Child Abuse Account is a major impetus in enabling the Judiciary to continue it’s proactive stance in dealing with the prevention and intervention of both domestic violence and child abuse and neglect. A comprehensive range of services and activities has been funded to victims of domestic violence and child abuse. Services to domestic violence offenders have also been improved and innovations have begun which have the potential to develop model best practices in this area. The Judiciary remains committed to using monies from the Special Account to continue efforts to promote the safety and well being of domestic violence and child abuse victims, and their families, in the State of Hawai#i. The Judiciary’s Spouse & Child Abuse Special Account Expenditures for Fiscal Year 2006-2007 Special Fund Assessment (Act 34, SLH 1964) 23,965 Purchase of Service
Load more

Recommended publications
  • Gabapentin Therapy in Psychiatric Disorders: a Systematic Review
    5/26/2017 Gabapentin Therapy in Psychiatric Disorders: A Systematic Review Prim Care Companion CNS Disord. 2015; 17(5): 10.4088/PCC.15r01821. PMCID: PMC4732322 Published online 2015 Oct 22. doi: 10.4088/PCC.15r01821 Gabapentin Therapy in Psychiatric Disorders: A Systematic Review Rachel K. Berlin, MD,a Paul M. Butler, MD, PhD,b and Michael D. Perloff, MD, PhDc,* a Department of Psychiatry, Cambridge Health Alliance, Cambridge, Massachusetts b Department of Neurology, Tufts University School of Medicine, Tufts Medical Center, Boston, Massachusetts c Department of Neurology, Boston University School of Medicine, Boston University Medical Center, Boston, Massachusetts * Corresponding author: Michael D. Perloff, MD, PhD, Department of Neurology, Boston University School of Medicine, 72 E. Concord St, C3, Boston, MA 02118 ([email protected]). Received 2015 Apr 7; Accepted 2015 Jun 12. Copyright © 2015, Physicians Postgraduate Press, Inc. Abstract Objective: Gabapentin is commonly used off­label in the treatment of psychiatric disorders with success, failure, and controversy. A systematic review of the literature was performed to elucidate the evidence for clinical benefit of gabapentin in psychiatric disorders. Data sources: Bibliographic reference searches for gabapentin use in psychiatric disorders were performed in PubMed and Ovid MEDLINE search engines with no language restrictions from January 1, 1983, to October 1, 2014, excluding nonhuman studies. For psychiatric references, the keywords bipolar, depression, anxiety, mood, posttraumatic stress disorder (posttraumatic stress disorder and PTSD), obsessive­compulsive disorder (obsessive­compulsive disorder and OCD), alcohol (abuse, dependence, withdraw), drug (abuse, dependence, withdraw), opioid (abuse, dependence, withdraw), cocaine (abuse, dependence, withdraw), and amphetamine (abuse, dependence, withdraw) were crossed with gabapentin OR neurontin.
    [Show full text]
  • Pharmacotherapy for Methamphetamine/Amphetamine Use Disorder—A Systematic Review and Meta-Analysis
    REVIEW doi:10.1111/add.14755 Pharmacotherapy for methamphetamine/amphetamine use disorder—a systematic review and meta-analysis Brian Chan1,2, Michele Freeman3 , Karli Kondo3, Chelsea Ayers3, Jessica Montgomery3, Robin Paynter3 & Devan Kansagara1,3,4 Division of General Internal Medicine and Geriatrics, Oregon Health and Science University, Portland, OR, USA,1 Central City Concern, Portland, OR, USA,2 Evidence- based Synthesis Program Center, VA Portland Health Care System, Portland, USA3 and Department of Medicine, VA Portland Health Care System, Portland, OR, USA4 ABSTRACT Aims Addiction to methamphetamine/amphetamine (MA/A) is a major public health problem. Currently there are no pharmacotherapies for MA/A use disorder that have been approved for use by the US Food and Drug Administration or the European Medicines Agency. We reviewed the effectiveness of pharmacotherapy for MA/A use disorder to assess the qual- ity, publication bias and overall strength of the evidence. Methods Systematic review and meta-analysis. We searched multiple data sources (MEDLINE, PsycINFO and Cochrane Library) to April 2019 for systematic reviews (SRs) and randomized controlled trials (RCTs). Included studies recruited adults who had MA/A use disorder; sample sizes ranged from 19 to 229 participants. Outcomes of interest were abstinence, defined as 3 or more consecutive weeks with negative urine drug screens (UDS); overall use, analyzed as the proportion of MA/A negative UDS specimens; and treatment reten- tion. One SR of pharmacotherapies for MA/A use disorder and 17 additional RCTs met our inclusion criteria encompassing 17 different drugs (antidepressants, antipsychotics, psychostimulants, anticonvulsants and opioid antagonists). We combined the findings of trials with comparable interventions and outcome measures in random-effects meta-analyses.
    [Show full text]
  • One That Is Easily Upset by Innovation
    HYTHIAM, INC. | 2006 ANNUAL REPORT a delicate balance exists between the status quo and revolutionary change, one that is easily upset by innovation Dear Shareholder: Since last year, we at Hythiam have been busy building the knowledge, resources and infrastructure required for us to capitalize on and make widely accessible the value inherent in the PROMETA® treatment protocols. The most important metric for us will always be the number of lives we impact. Terren S. Peizer Chairman of the Board and Chief Executive Officer We are pleased to report that over 1,500 patients have been always been our view that maintaining long-term abstinence treated to date, and the number continues to steadily increase. requires psychosocial intervention since environment and behavioral patterns are such a big part of the equation, but only Many of the elements necessary for a dramatic shift to occur in if the physiological factors such as cravings and cognition have the current paradigm of addiction treatment are now in place, been addressed first. This especially applies for the alcohol- and we believe that Hythiam’s integrated PROMETA treatment dependent individual, since alcohol is both legal and ubiquitous protocols will be an integral part of that change. Everything in society and culture. Also, since this was the first study for we have accomplished thus far has been because PROMETA alcohol-dependent subjects, Dr. Wilkins measured the effect represents hope that there is a better way to treat addictive of a prior version of the medical component of PROMETA that disorders and their associated issues. For the patients and was in use at that time, one that included only two consecutive their families, PROMETA represents recovery.
    [Show full text]
  • Treating Substance Abuse •
    • Treating Substance rain Abuse Theory and Technique usance Third Edition Theor.y and USeTechmque Edited by Scott 1. Walters Frederick Rotgers THIRD EDITIO ~ THE GUILFORD PRESS . New York London 2B2 TREATING SUBSTANCE ABUSE Chapter 11 This chapter first presents the basics of brain function, including the neurotransmitters and pathways involved in substance abuse. This under­ standing provides the foundation for the subsequent presentation of medi­ Neurobiological Bases cations used to treat addictive disorders. This chapter focuses on medi­ cations approved by the U.S. Food and Drug Administration (FDA) for of Addiction Treatment alcohol dependence and opioid dependence with an overview of promis­ ing new developments for stimulant and cannabis dependence. (Carroll & Kiluk. Chapter 12, this volume) in this book talks more specifically about Philip H. Chung integrating psychotherapy with pharmacotherapy. Julie D. Ross Sidarth Wakhlu Brain Basics Bryon Adinoff Neurons and the Brain MicroscopicaHy, the brain is composed of a collection of cells, or neurons, that signal one another both chemically and electrically. Electrical signals are lIsed to communicate within cells, and chemical signals are used to com­ municate between cells. Most neurons have a characteristic structure that consists of a globular cell body with numerous long, spindly projections coming off the central cell body (Figure 11.1). These projections are used in the process of signaling between neurons and receive communications from their sometimes-distant cell bodies. The axon of a signaling cell projects to ovcr the past two decades stunning progress has been made in the dendrite of the receiving cell, and the twO projections come into dose understanding the psychopathology of addiction.
    [Show full text]
  • PDF (Double-Blind Placebo-Controlled Evaluation of the PROMETA Protocol for Methamphetamine Dependence)
    Your selected document Your selected document This entry is our account of a study selected by Drug and Alcohol Findings as particularly relevant to improving outcomes from drug or alcohol interventions in the UK. Unless indicated otherwise, permission is given to distribute this entry or incorporate passages in other documents as long as the source is acknowledged including the web address http://findings.org.uk. The original study was not published by Findings; click on the Title to obtain copies. Free reprints may also be available from the authors – click prepared e-mail to adapt the pre-prepared e-mail message or compose your own message. Links to source documents are in blue. Hover mouse over orange text for explanatory notes. The Summary is intended to convey the findings and views expressed in the study. Below are some comments from Drug and Alcohol Findings. Open home page. Register for free e-mail alerts about new studies. Search for studies by topic or do a free text search. Double-blind placebo-controlled evaluation of the PROMETATM protocol for methamphetamine dependence. Ling W., Shoptaw S., Hillhouse M. et al. Addiction: 2012, 107(2), p. 361–369. Unable to obtain a copy by clicking title above? Try asking the author for a reprint (normally free of charge) by adapting this prepared e-mail or by writing to Dr Hillhouse at [email protected]. You could also try this alternative source. The US company which owns and markets the controversial PROMETA proprietary combination of drugs for methamphetamine dependence funded a rigorous trial by independent researchers; the result was a no-better-than-placebo verdict, another negative in the search for drugs to counter stimulant dependence.
    [Show full text]
  • Use of Gabapentin in the Treatment of Substance Use and Psychiatric Disorders: a Systematic Review
    University of Texas Rio Grande Valley ScholarWorks @ UTRGV School of Medicine Publications and Presentations School of Medicine 5-2019 Use of Gabapentin in the Treatment of Substance Use and Psychiatric Disorders: A Systematic Review Saeed Ahmed Ramya Bachu Vijaya P. Kotapati Mahwish Adnan Rizwan A. Ahmed See next page for additional authors Follow this and additional works at: https://scholarworks.utrgv.edu/som_pub Part of the Psychiatry and Psychology Commons Recommended Citation Ahmed S, Bachu R, Kotapati P, Adnan M, Ahmed R, Farooq U, Saeed H, Khan AM, Zubair A, Qamar I, Begum G. Use of Gabapentin in the Treatment of Substance Use and Psychiatric Disorders: A Systematic Review. Front Psychiatry. 2019 May 7;10:228. doi: 10.3389/fpsyt.2019.00228. PMID: 31133886; PMCID: PMC6514433. This Article is brought to you for free and open access by the School of Medicine at ScholarWorks @ UTRGV. It has been accepted for inclusion in School of Medicine Publications and Presentations by an authorized administrator of ScholarWorks @ UTRGV. For more information, please contact [email protected], [email protected]. Authors Saeed Ahmed, Ramya Bachu, Vijaya P. Kotapati, Mahwish Adnan, Rizwan A. Ahmed, Umer Farooq, Hina Saeed, Ali M. Khan, Aarij Zubair, Iqra Qamar, and Gulshan Begum This article is available at ScholarWorks @ UTRGV: https://scholarworks.utrgv.edu/som_pub/202 SYSTEMATIC REVIEW published: 07 May 2019 doi: 10.3389/fpsyt.2019.00228 Use of Gabapentin in the Treatment of Substance Use and Psychiatric Disorders: A Systematic Review Saeed Ahmed 1, Ramya Bachu 2*, Padma Kotapati 3, Mahwish Adnan 4, Rizwan Ahmed 5, Umer Farooq 6, Hina Saeed 7, Ali Mahmood Khan 8, Aarij Zubair 9, Iqra Qamar 10 and Gulshan Begum 11 1 Nassau University Medical Center, East Meadow, NY, United States, 2 Department of Internal Medicine, Baptist Health- UAMS, Little Rock, AR, United States, 3 Manhattan Psychiatric Center, New York, NY, United States, 4 McMaster University, Hamilton, ON, Canada, 5 Liaquat National Medical College, Karachi, Pakistan, 6 John T.
    [Show full text]
  • IHS Primary Care Provider Newsletter
    THE IHS PRIMARY CARE PROVIDER A journal for health professionals working with American Indians and Alaska Natives April 2007 Volume 32 Number 4 Treatment for Methamphetamine Abuse and Dependence: The Matrix Model Jeanne L. Obert, MFT, MSM, Executive Director, Matrix Matrix Model in Indian Country Institute on Addictions, Los Angeles, California; Sam Minsky, While the use of methamphetamine increased across the MA, MFT, Executive Trainer, Matrix Institute on Addictions, nation, it skyrocketed in the AI/AN population. In August Los Angeles; and Glenn Cummings, MA, LISAC, LPC, Clinical 2006, the Desert Sun newspaper reported, Services/Training Coordinator, Gila River Indian Community, Dept. of Human Services, Sacaton, Arizona “In the past few years, meth has replaced alcohol as the No. 1 substance abuse problem in Indian country, Background The Matrix Model is an evidence-based psychosocial treatment used to treat stimulant dependence. Although the In this Issue… primary goal for the originators of the Matrix Model was to develop an effective outpatient treatment for cocaine, they later 97 Treatment for Methamphetamine Abuse and successfully extended the treatment to methamphetamine. As Dependence: The Matrix Model the methamphetamine epidemic spread eastward across the US, the Matrix Model gained popularity,1-3 and in 1999 the 97 Methamphetamine Abuse in Indian Country Center for Substance Abuse Treatment sponsored a large scale 99 Executive Development Leadership Program randomized clinical trial of the Matrix Model.4 100 Taking Control of Methamphetamine in Our Methamphetamine Abuse in Indian Country Communities: An Opportunity of Necessity 101 Promising Practices for Treating Methamphetamine Lori De Ravello, MPH, CDC Assignee to the National Use Disorders STD Program, volunteered to coordinate two special issues of The IHS Provider dedicated to the problem of 104 A Special Care Clinic for Substance Abuse methamphetamine abuse in Indian Country.
    [Show full text]
  • Pharmacologcial Treatments for Methamphetamine Use Disorder
    Abstract Background: Methamphetamine use disorder is a persistent and prevalent illness associated with serious physical, emotional, cognitive and social harms. No proven pharmacological treatments have yet been identified and psychological therapies are currently the only evidence based treatments. A recent systematic review and meta-analysis found no quantitative evidence of benefit for psychostimulants in achieving abstinence or retention in treatment, but that review was limited to specific pharmacological agents (Bhatt et al, 2016). An older systematic review examined all treatments and found no single agent that demonstrated consistent efficacy (Brackins et al, 2011). Many additional studies have since been published. The aim of this systematic review is to critically evaluate the literature not previously covered by these and examine the evidence for efficacy of all possible pharmacological treatments. Methods: The literature search strategy consisted of an electronic search of PubMed. I included randomized controlled trials not previously reviewed of any pharmacological treatment for methamphetamine use disorder that reported methamphetamine use by urine drug screen as an outcome. I abstracted data from all identified studies using a standardized data collection instrument and critically analyzed the risk of bias, internal validity and external validity of all studies using a standardized form. I synthesized the review data. Results: I identified and analyzed 11 studies not previously reviewed. Pharmacological treatments used in these studies included buprenorphine, N-acetyl-cysteine, aripiprazole, citocoline, topiramate, naltrexone, mirtazapine, and a combined regimen of flumazenil/gabapentin/hydroxyzine. No study was found to have both good internal and good external validity. The overall level of internal validity within studies was severely limited by i small study size and high numbers of drop outs.
    [Show full text]
  • Perspectives on Hythiam's Prometa Treatment for Addiction
    VOL. 33/NO. 1 • FALL 2006 THE VOICE FOR TREATMENT QUARTERLY NEWSLETTER OF THE CALIFORNIAnews SOCIETY OF ADDICTION MEDICINE CSAM Introduces New Forum for Dialogues in Addiction Medicine Perspectives on Hythiam’s Prometa Treatment for Addiction BY TIMMEN CERMAK, MD, EDITOR As the new editor of CSAM’s Newsletter, I am excited to and most especially introduce the FORUM. Each newsletter, I will choose an issue when the treatment has that would benefit from being elevated to the surface, where not yet met the most open discussion of different perspectives can advance our rigorous tests for safety understanding of the issue, and of each other. Views will be and efficacy. This issue ADDICTION MEDICINE presented not in a Pro-Con, Point-Counterpoint framework, transcends addiction but rather as examples of differing perspectives. Dialogue will medicine, pervading the be the most important goal for each FORUM. whole of medicine. We FORUM will not resolve it on our FORUM Commentary own without a resolution that involves the entire pharmaceu- tical industry’s relationship to medicine. However, where we There are two important themes threading through the feel the best interests of those suffering from addictive disease two perspectives on Hythiam’s Prometa that possess par- are being impacted, we have an obligation to identify and de- ticular relevance for addiction medicine, both in terms of bate that impact. The issues here are complex. In a free society, their impact on the practice of treating addiction and the it is often difficult to distinguish between brave and innovative special expertise practioners in our field can bring to an approaches being championed by a few and treatments that understanding of these themes.
    [Show full text]
  • Medication Treatment Options for Amphetamine-Type Stimulant Users / Leejenn Health Consultants; (Nicole Lee & Linda Jenner)
    29 Medication paper ANCD research treatment options for amphetamine-type stimulant users 29 Medication paper ANCD research treatment options for amphetamine-type stimulant users LeeJenn Health Consultants A discussion paper prepared for the Australian National Council on Drugs, November 2013 © Australian National Council on Drugs 2014 This work is copyright. Apart from any use as permitted under the Copyright Act 1968, no part may be reproduced by any process without the written permission of the publisher. Published by the Australian National Council on Drugs PO Box 205, Civic Square ACT 2608 Telephone: 02 6166 9600 Fax: 02 6162 2611 Email: [email protected] Website: www.ancd.org.au National Library of Australia Cataloguing-in-Publication entry Medication treatment options for amphetamine-type stimulant users / LeeJenn Health Consultants; (Nicole Lee & Linda Jenner). ISBN: 9781877018329 (ebook) ANCD research paper; 29. Includes bibliographical references. Amphetamine abuse — Treatment Amphetamines Stimulants Therapeutics Lee, Nicole Jenner, Linda LeeJenn Health Consultants Australian National Council on Drugs 616.864061 Editor: Julie Stokes Design: Inkwire, Canberra Acknowledgement: This work has been supported by funding from the Australian Government Department of Health and Ageing. The opinions expressed in this publication are those of the authors and are not necessarily those of the ANCD or the Australian Government. About the authors Nicole Lee is a practising psychologist, Associate Professor at the National Centre for Education and Training on Addiction at Flinders University, and holds adjunct appointments at Curtin and Monash universities. With Linda Jenner, she is co-director of LeeJenn Health Consultants. She has served on the boards of the Australasian Professional Society on Alcohol and other Drugs and the Alcohol and other Drugs Council of Australia, and was the Queensland, Victorian and National President of the Australian Association for Cognitive and Behaviour Therapy.
    [Show full text]
  • Pharmacotherapy for Stimulant Use Disorders: a Systematic Review
    4 D epartment of Veterans Affairs Health Services Research & Development Service Evidence-based Synthesis Program Pharmacotherapy for Stimulant Use Disorders: A Systematic Review August 2018 Prepared for: Investigators: Department of Veterans Affairs Principal Investigator: Veterans Health Administration Brian Chan, MD, MPH Quality Enhancement Research Initiative Co-Investigators: Health Services Research & Development Service Karli Kondo, PhD, MA Washington, DC 20420 Chelsea Ayers, BA Prepared by: Michele Freeman, MPH Jessica Montgomery, MPH Evidence-based Synthesis Program (ESP) Robin Paynter, MLIS Portland VA Health Care System Devan Kansagara, MD, MCR Portland, OR Devan Kansagara, MD, MCR, Director 4 Pharmacotherapy for Stimulant Use Disorders Evidence-based Synthesis Program PREFACE The VA Evidence-based Synthesis Program (ESP) was established in 2007 to provide timely and accurate syntheses of targeted healthcare topics of particular importance to clinicians, managers, and policymakers as they work to improve the health and healthcare of Veterans. QUERI provides funding for 4 ESP Centers, and each Center has an active University affiliation. Center Directors are recognized leaders in the field of evidence synthesis with close ties to the AHRQ Evidence-based Practice Centers. The ESP is governed by a Steering Committee comprised of participants from VHA Policy, Program, and Operations Offices, VISN leadership, field-based investigators, and others as designated appropriate by QUERI/HSR&D. The ESP Centers generate evidence syntheses on important clinical practice topics. These reports help: · Develop clinical policies informed by evidence; · Implement effective services to improve patient outcomes and to support VA clinical practice guidelines and performance measures; and · Set the direction for future research to address gaps in clinical knowledge.
    [Show full text]
  • 1 Curriculum Vitae Maureen P. Hillhouse April, 2021
    Hillhouse, M. P. Curriculum Vitae Maureen P. Hillhouse April, 2021 EMPLOYMENT CONTACT INFORMATION New York University 370 Jay Street, Twelfth Floor Brooklyn, NY 11201 [email protected] PERSONAL CONTACT INFORMATION 6424 Hazel Circle Simi Valley, CA 93063 805-404-3437 [email protected] EDUCATION California State University, Northridge B.A., Summa Cum Laude, Psychology, 1991 University of California, Los Angeles M. A., Psychology, 1993 University of California, Los Angeles Ph.D., Psychology, 1998 TEACHING EXPERIENCE 1993, Summer Teaching Assistant; Alcoholism, UCLA. 1993, Fall Teaching Assistant; Fundamentals of Learning, UCLA Taught six discussion sections. 1994, Winter Teaching Assistant; Alcoholism Honors Lab, UCLA 1994, Spring Teaching Assistant; Alcoholism, UCLA 1994, Summer Teaching Associate; Fundamentals of Learning, UCLA Taught three discussion sections. 1994, Fall Teaching Associate; Fundamentals of Learning, UCLA Taught five discussion sections. 1995, Winter Teaching Associate; Research Methods, UCLA 1995, Spring Teaching Associate; Fundamentals of Learning Taught six discussion sections. 1 Hillhouse, M. P. 1995, Fall Teaching Associate; Research Methods, UCLA 1996, Winter-Spring Teaching Associate/Research Coordinator; UCLA Developmental Disabilities Immersion Program (DDIP) 1996, Summer Teaching Associate; Alcoholism, UCLA PROFESSIONALEXPERIENCE 2016-Present New York University Marron Institute Senior Research Scholar 2015-2016 Pepperdine University School of Public Policy Project Director 2009- 2015 University of California,
    [Show full text]